Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Detection of hepatotoxicity by means of blood coagulation changes

Abstract

The relationship between blood coagulation and hepatic damage is well established but has been largely ignored as a means of detecting hepatotoxicity in regulatory safety evaluation, especially in rodent studies. In the main this has been due to the limitations of the laboratory techniques available for the assessment of clotting times in small amounts of blood.

Carbon tetrachloride and butylated hydroxytoluene (BHT) were chosen as model hepatotoxic compounds and administered at doses designed to produce liver damage within 24 h. Classic centrilobular necrosis was induced with carbon tetrachloride but the effect of BHT was negligible, contrary to published evidence. The clotting potential was monitored by means of the standard one-stage prothrombin time using species-homologous brain reagent and by a modified commercially available reagent (Thrombotest) which is more specific for the coagulation factors involved with the one-stage reaction. Thrombotest was demonstrated to be more sensitive than the conventional one-stage prothrombin time method and to have a number of clear practical advantages for use with small rodents. Its use in regulatory toxicology is recommended.

This is a preview of subscription content, log in to check access.

References

  1. Hall DE (1970) Sensitivity of different thromboplastin reagents to factor VII deficiency in the blood of beagle dogs. Lab Anim 4:55–59.

  2. Hart JE (1987) Vitamin K-dependent blood clotting changes in female rats treated with oestrogens. Thromb Haemos 57:273–277.

  3. Hart JE, Lascombe SM, Hall DE, Parke DV (1979) The effect of oestrogens on blood clotting in the rat. Thromb Haemost 42:1069–1070.

  4. Jackson GM (1985) PhD thesis. University of Surrey.

  5. Mifsud CV (1979) The sensitivity of various thromboplastins in different animal species. Pharmacol Ther 5:251–256.

  6. Owren PA (1959) Thrombotest: a new method for controlling anticoagulant therapy. Lancet 754–758.

  7. Pritchard DJ, Wright MG, Sulsh S and Butler WH (1987). The assessment of chemically-induced liver injury in rats. J Appl Toxicol 7:229–236.

  8. Spurling NW, Burton LK and Pilling T. (1974) Canine factor-VII deficiency: experience with a modified thrombotest method in distinguishing between the genotypes. Res Vet Sci 16:228–239.

  9. Suttie JW (1978) Vitamin K In De Luca HF (ed.) the Handbook of Lipid Research, vol. 2. Fat soluble vitamins. Plenum Press, New York and London pp. 211–277.

  10. Takahashi O (1987) Decrease in blood coagulation factors II (prothrombin), VII, IX and X in the rat after a single oral dose of butylated hydroxytoluene. Food & Chem Toxicol, 25:219–24.

  11. Takahashi O, Hiraga K (1978) Dose-response study of haemorraghic death by dietary butylated hydroxytoluene (BHT) in male rats. Toxicol App Pharmacol 43:399–420.

  12. Thomson JM (1970) A practical guide to blood coagulation and haemostasis. Churchill-Livingstone, London, pp. 123–131.

  13. Vainien H, Wingard LB Jr (1977) Effect of warfarin on the kinetics of the vitamin K dependent clotting factors in rats. J Pharmacol Exp Ther 201:507–517.

  14. Zimmermann HJ (1978) Direct (toxipathic) hepatotoxins in The adverse effects of drugs and other chemicals upon the liver. Appleton-Century-Crofts, New York, pp. 199–219.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schofield, M.A., Hall, D.E. Detection of hepatotoxicity by means of blood coagulation changes. Comparative Haematology International 1, 200–204 (1991). https://doi.org/10.1007/BF00235370

Download citation

Keywords

  • Prothrombin time
  • Hepatotoxicity
  • Blood coagulation
  • Thrombotest